Ken Griffin Apollo Endosurgery, Inc. Transaction History

Citadel Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.83 - $9.96 $31,436 - $31,852	3,198 Added 30.7%	13,615 $135,000
Q4 2022 Feb 14, 2023	SELL	$5.91 - $10.14 $328,655 - $563,885	-55,610 Reduced 84.22%	10,417 $103,000
Q3 2022 Nov 14, 2022	SELL	$3.65 - $6.74 $13,797 - $25,477	-3,780 Reduced 5.41%	66,027 $363,000
Q2 2022 Aug 15, 2022	BUY	$3.65 - $6.04 $144,050 - $238,374	39,466 Added 130.07%	69,807 $255,000
Q1 2022 May 16, 2022	SELL	$5.01 - $8.77 $215,810 - $377,776	-43,076 Reduced 58.67%	30,341 $183,000
Q4 2021 Feb 14, 2022	BUY	$7.64 - $10.11 $360,799 - $477,444	47,225 Added 180.3%	73,417 $618,000
Q3 2021 Nov 15, 2021	SELL	$7.35 - $9.93 $110,602 - $149,426	-15,048 Reduced 36.49%	26,192 $237,000
Q2 2021 Aug 16, 2021	BUY	$5.37 - $8.95 $74,154 - $123,590	13,809 Added 50.34%	41,240 $334,000
Q1 2021 May 17, 2021	BUY	$3.54 - $6.46 $97,105 - $177,204	27,431 New	27,431 $151,000
Q1 2020 May 15, 2020	SELL	$1.27 - $3.19 $13,662 - $34,318	-10,758 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.65 - $3.4 $28,508 - $36,577	10,758 New	10,758 $31,000

527K

Ticker APEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,686,500
Description
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.